Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$94,984,772
+$34,791,916 QoQ
Shares Held
890,872
+142.0% QoQ
Ownership
0.408%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#47
of 665 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. INSM ranks #17 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELVN |
Enliven Therapeutics, Inc.
|
6,430,636 | $326,354,777 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,570,556 | $275,878,760 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,253,649 | $191,988,358 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,663,632 | $184,713,060 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
6,606,945 | $173,234,097 | |
| 6 | ASND |
Ascendis Pharma A/S
|
616,908 | $164,541,701 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
2,063,609 | $153,697,598 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
482,751 | $145,322,533 |
All Filings in INSM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,984,772 | 890,872 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $60,192,856 | 368,107 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $59,909,441 | 344,228 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $53,555,446 | 371,887 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $70,242,694 | 697,960 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $55,596,718 | 728,755 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $50,399,200 | 730,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $49,640,000 | 680,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,085,000 | 255,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,828,621 | 251,700 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,627,482 | 504,275 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,750,350 | 861,400 | Shares | Defined | 2023-11-22 | |
| 2023-06-30 | $35,687,463 | 1,691,349 | Shares | Defined | 2023-12-13 | |
| 2023-03-31 | $28,837,500 | 1,691,349 | Shares | Defined | 2023-12-13 | |
| 2022-12-31 | $30,796,153 | 1,541,349 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $29,969,657 | 1,391,349 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,460,062 | 631,849 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,848,451 | 631,849 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $48,983,213 | 1,798,209 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $49,522,675 | 1,798,209 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,651,025 | 936,438 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $31,895,078 | 936,438 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $23,346,310 | 701,301 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||